Clarion Capital Partners
Clarion Capital Partners is a New York-based private equity investment firm established in 1999. The firm specializes in making control investments in a diversified portfolio of middle-market companies, primarily focusing on growth-stage firms across various sectors, including business services, healthcare, specialty financial services, consumer products, and media and entertainment. Clarion typically invests between $15 million and $50 million in companies with enterprise values ranging from $50 million to $200 million. The firm employs a variety of investment structures, such as leveraged buyouts and growth equity, to tailor capital solutions to the specific needs of each business. As a Registered Investment Adviser, Clarion Capital Partners actively seeks opportunities to enhance the growth and prospects of its portfolio companies.
Private Equity Round in 2021
Recognized by Inc. Magazine as the 37th fastest growing private company in America, OpenRoad Lending is your auto loan specialist assisting you in finding the best auto loan terms for your new or used car purchase or by helping you save money by refinancing your existing vehicle. Headquartered in the Dallas/Fort Worth area and chosen as one of the Best Places to Work by the Dallas Business Journal, they provide loan products to customers throughout the country and their staff has helped tens of thousands of consumers just like you get into the car or truck of their dreams. With OpenRoad, you are in the driver’s seat when it comes to the full details of your loan. No hidden costs, no application fees – just a great rate, easy process and award-winning customer service experience to help you along the way.
Private Equity Round in 2019
Harris & Harris provides accounts receivable management services to the healthcare, government, and utilities industries.
Private Equity Round in 2018
Premiere Digital Services is a cloud-based digital asset management and storage platform for the media and entertainment industries. They provide the entertainment industry and international brands with the tools they need to process, package, and deliver digital content anywhere.
Private Equity Round in 2017
AML RightSource is a provider of anti-money laundering (AML) and financial crime compliance services. It also offers transaction monitoring, alert backlog management, due diligence reviewing, and financial crimes advisory services through its team of highly-trained professionals that enable financial institutions to maintain day-to-day compliance services. It was founded in 2004 and is headquartered in Cleveland, Ohio.
Madison Logic empowers B2B marketers to convert their best accounts faster by finding and engaging with the most influential individuals throughout the buyer’s journey. The ML Platform, a global multi-channel ABM media activation and measurement solution, enables enterprise organizations to leverage unique proprietary data to identify the accounts most likely to purchase, accelerate the customer journey, and shorten sales cycles to positively impact ROI.
At The Oceanaire Seafood Room, their commitment to freshness sets us apart from the rest. Only top-of-the-catch fish from the world's most reputable suppliers is served, and each dish is carefully crafted to ensure the restaurant's high standards of quality and flavor are exceeded. The menu is based on market availability, therefore their selections change each day.
Strategic Outsourcing, Inc. (SOI) is one of the largest providers of Professional Employer Organization (PEO) services in the United States. Based in Charlotte, North Carolina, the Company has been active in the PEO industry through its predecessor companies since 1990.
Pharmacopeia, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to address significant medical needs. Its internal program portfolio comprises PS433540, a dual-acting angiotensin and endothelin receptor antagonist, which is in phase II clinical development for the treatment of cardiovascular and renal diseases, including hypertension and diabetic nephropathy; and PS178990, a muscle selective SARM agonists that is in phase I clinical development. The company's products also include PS031291, a preclinical development product for the treatment of multiple myeloma and various inflammatory diseases, including rheumatoid arthritis; and JAK3 inhibitors for T-cell and cytokine mediated dermatologic and ocular diseases, such as psoriasis and dry eye. Pharmacopeia has strategic alliances with Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals. The company was founded in 1993. It was formerly known as Pharmacopeia Drug Discovery, Inc. and changed its name to Pharmacopeia, Inc. in May 2007. Pharmacopeia is based in Cranbury, New Jersey. As of December 23, 2008, Pharmacopeia, Inc. operates as a subsidiary of Ligand Pharmaceuticals Inc.
KP Engineering offers the energy industry with process-driven engineering, procurement, and construction solutions. It offers consulting and project management services for the refining, oil production, petrochemical, and gas processing industries. KP Engineering offers services that focus on process and scope development, engineering design, technology evaluations, fabrication, field construction, and more. KP Engineering was founded in 2004 and is based in Tyler, Texas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.